Clinical Trial Update: Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa [Phase 3]

View source ↗

Summary

Phase 3 study evaluating aztreonam for inhalation solution (AZLI) in cystic fibrosis patients with Pseudomonas aeruginosa has completed and results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Cayston (aztreonam lysine)

Snippet

Sponsor: Gilead Sciences | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2011-03-11